Ferdia Bates

Title: Ferdia Bates: Innovator in RNA Therapeutics

Introduction

Ferdia Bates is a prominent inventor based in Mainz, Germany. He has made significant contributions to the field of RNA therapeutics, particularly in the preparation and storage of liposomal RNA formulations. With a total of 2 patents, his work is paving the way for advancements in medical therapies.

Latest Patents

Ferdia Bates' latest patents focus on the preparation and storage of liposomal RNA formulations suitable for therapy. The first patent discloses methods for preparing RNA lipoplex particles for the delivery of RNA to target tissues after parenteral administration, especially after intravenous administration. It also includes compositions comprising such RNA lipoplex particles. Furthermore, the patent outlines methods that allow for the industrial GMP-compliant preparation of RNA lipoplex particles. Additionally, it discusses methods and compositions for storing RNA lipoplex particles without substantial loss of product quality and RNA activity.

Career Highlights

Ferdia Bates is currently associated with BioNTech SE, a leading biotechnology company known for its innovative approaches to vaccine development and RNA-based therapies. His work at BioNTech has positioned him at the forefront of research in RNA delivery systems.

Collaborations

Ferdia collaborates with notable colleagues, including Heinrich Haas and Sebastian Hörner. Their combined expertise contributes to the advancement of RNA therapeutic technologies.

Conclusion

Ferdia Bates is a key figure in the field of RNA therapeutics, with his innovative patents and contributions to BioNTech SE. His work continues to influence the development of effective RNA delivery systems for therapeutic applications.